Correction to: Nature Medicine https://doi.org/10.1038/s41591-023-02597-w, published online 15 October 2023.
In the originally published version of this article, the labels in the Fig. 2 key for panels b and f (now shown as “Tirzepatide MTD” and “Placebo” for the inverted blue triangle and white box, respectively) were swapped. This error has been corrected in the HTML and PDF versions of the article.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Wadden, T.A., Chao, A.M., Machineni, S. et al. Author Correction: Tirzepatide after intensive lifestyle intervention in adults with overweight or obesity: the SURMOUNT-3 phase 3 trial. Nat Med (2024). https://doi.org/10.1038/s41591-024-02883-1
Published:
DOI: https://doi.org/10.1038/s41591-024-02883-1
